InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 306154

Sunday, 08/05/2018 11:35:29 PM

Sunday, August 05, 2018 11:35:29 PM

Post# of 346140

What changes have Ziopharm made after patient deaths, especially with Dr Jedd Wolchok on board with Ziopharm and knowing PS Targeting reduces off Target toxicities ?



I do believe Hagop Youssoufian was leading Ziopharm and close ties to Dr Jedd Wolchok....now leading along with Oncologie and PS Targeting IP

Tomorrow would be a good day for more news from Avid
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News